Medicine and health technology has expanded over the years as we have learnt more and more about the human body and the way it works as well as how medicines can help with a number of different illnesses and diseases. In order to ensure that new medicines are tested properly studies are undertaken in the way in which they work and how they can help an individual.
Adaptive Phase 1 Studies like the ones you can see at https://www.richmondpharmacology.com/specialist-services/adaptive-phase-i-studies are one such type of study. These are studies that are undertaken during the early parts of the development of a treatment or a drug. They are much more flexible in the parameters that can be used than your traditional clinical study and the parameters can be adapted over time if necessary. This leads to quicker and less expensive studies to take place. They are equally as safe as clinical studies but can offer more timely results which in turn has an impact on the number of people that can be helped in the general population from the findings of the drug or treatment study. The ability to adapt the study as a result of the information that is fed back by the patients that take part in the study means that the study can adapt and provide really clear results to the medical community.